Gerard Bannenberg is the current Director of Compliance and Scientific Outreach at the Global Organization for EPA and DHA Omega-3s (GOED). He coordinates the technical committee and supports members of the association in technical and scientific matters. He received a doctorate in Molecular Toxicology (1994) at the Institute of Environmental Medicine at the Karolinska Institute in Stockholm, Sweden, and his undergraduate degree (1989) at the Centre for Bio-Pharmaceutical Sciences at Leiden University, The Netherlands.
Gerard Bannenberg has published research on poly-unsaturated fatty acid-derived lipid mediators and on the mechanisms whereby the body regulates inflammation and protects itself from oxidative injury. He is an affiliate member of the Center for Experimental Therapeutics and Reperfusion Injury, Department of Anesthesiology, Perioperative and Pain Medicine, at Brigham & Women’s Hospital, Boston MA. He has worked as scientific officer at Solutex, a Spanish high-technology company producing highly defined EPA and DHA concentrates. He has also served as a board member of GOED, and co-founded the European Workshop on Lipid Mediators, a bi-annual conference series dedicated to promoting the understanding of bioactive lipids. Recent research has focused on the assessment of EPA/DHA omega-3 oil quality.